Literature DB >> 17118678

Microinjections of the dopamine D2 receptor antagonist sulpiride into the medial prefrontal cortex attenuate glucocorticoid-induced impairment of long-term memory retrieval in rats.

Roghayeh Pakdel1, Ali Rashidy-Pour.   

Abstract

We recently reported that blockade of dopamine (DA) D2 receptors attenuated deficits in long-term memory retrieval induced by a systemic injection of corticosterone, but the anatomical sites of such interaction were not known. In this study, we investigated whether the DA D2 receptors located in the medial prefrontal cortex (mPFC) may play a role in the impairing effects of glucocorticoids on the memory retrieval process. Young adult male rats were trained in a one trial inhibitory avoidance task (0.5 mA, 3s footshock). On the retention test given 48 h after training, the latency to re-enter the dark compartment and the time spent in light compartment of the apparatus were recorded. Systemically administered corticosterone (1mg/kg) given to rats 30 min before retention testing impaired their memory retrieval. Bilateral microinjections of the DA D2 receptor antagonist sulpiride (10 or 100 ng/0.5 microl per side) into the mPFC 30 min before corticosterone administration attenuated the glucocorticoid-induced impairment of memory retrieval. Furthermore, applied doses of sulpiride alone were ineffective in modulating memory retrieval. These findings indicate that D2 receptors located in the mPFC play an important role in mediating the impairing effects of glucocorticoids on memory retrieval.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17118678     DOI: 10.1016/j.nlm.2006.10.002

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  7 in total

Review 1.  Cognitive enhancers for anxiety disorders.

Authors:  Stefan G Hofmann; Jasper A J Smits; Anu Asnaani; Cassidy A Gutner; Michael W Otto
Journal:  Pharmacol Biochem Behav       Date:  2010-12-04       Impact factor: 3.533

2.  Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes.

Authors:  Michael W Otto; R Kathryn McHugh; Kathleen M Kantak
Journal:  Clin Psychol (New York)       Date:  2010-06-08

3.  Endocrine active metals, prenatal stress and enhanced neurobehavioral disruption.

Authors:  Marissa Sobolewski; Katherine Conrad; Elena Marvin; Joshua L Allen; Deborah A Cory-Slechta
Journal:  Horm Behav       Date:  2018-02-01       Impact factor: 3.587

4.  D1, but not D2, receptor blockade within the infralimbic and medial orbitofrontal cortex impairs cocaine seeking in a region-specific manner.

Authors:  Caitlin V Cosme; Andrea L Gutman; Wensday R Worth; Ryan T LaLumiere
Journal:  Addict Biol       Date:  2016-08-31       Impact factor: 4.280

5.  Amygdala-prefrontal pathways and the dopamine system affect nociceptive responses in the prefrontal cortex.

Authors:  Kitaro Onozawa; Yuki Yagasaki; Yumi Izawa; Hiroyuki Abe; Yoriko Kawakami
Journal:  BMC Neurosci       Date:  2011-11-15       Impact factor: 3.288

6.  Pre-gestational stress alters stress-response of pubertal offspring rat in sexually dimorphic and hemispherically asymmetric manner.

Authors:  Yuejun Huang; Sihong Chen; Hongwu Xu; Xiaochan Yu; Huihong Lai; Guyu Ho; Qingjun Huang; Xuechuan Shi
Journal:  BMC Neurosci       Date:  2013-07-08       Impact factor: 3.288

7.  Neuroenhancement of Exposure Therapy in Anxiety Disorders.

Authors:  Stefan G Hofmann; Elizabeth A Mundy; Joshua Curtiss
Journal:  AIMS Neurosci       Date:  2015
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.